Holen Sie sich die Stockscreener-App
11.06
0.64%
0.0661
Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
97.31%
0.38
|
14.12 | 18.17 | 211.19 | 3.042 |
Operating Expenses
|
0.03%
29.66
|
29.65 | 57.98 | 59.21 | 56.30 |
| Benefits Costs and Expenses |
11.07%
25.36
|
22.83 | 51.09 | 52.70 | 190.60 |
| Costs And Expenses |
11.07%
25.36
|
22.83 | 51.09 | 52.70 | 32.52 |
| Operating Income/Loss |
90.26%
-29.27
|
-15.38 | -39.82 | 152.04 | -53.25 |
| Nonoperating Income/Loss |
35.70%
4.295
|
6.68 | 6.899 | 6.454 | 7.528 |
| Income/Loss From Continuing Operations Before Tax |
186.94%
-24.98
|
-8.704 | -32.92 | 158.49 | -187.56 |
| Income Tax Expense/Benefit |
6.32%
-1.514
|
-1.424 | -2.222 | 10.04 | - |
| Income/Loss From Continuing Operations After Tax |
222.27%
-23.46
|
-7.28 | -30.70 | 148.45 | -46.03 |
|
Net Income/Loss
|
222.27%
-23.46
|
-7.28 | -30.70 | 148.45 | -46.03 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
108.31%
-3.3776
|
40.62 | 40.61 | 40.56 | 0.9737 |
| Diluted Average Shares |
108.23%
-3.3433
|
40.62 | 40.61 | 41.02 | 0.9737 |
| Basic Earnings Per Share |
111.11%
-0.38
|
-0.18 | -0.76 | 3.66 | -1.12 |
| Diluted Earnings Per Share |
111.11%
-0.38
|
-0.18 | -0.76 | 3.62 | -1.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):